A. , M. Rius, C. Hermenegildo, and C. , Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan, J Immunol, vol.183, pp.1393-402, 2009.

A. , B. M. Hardy, E. M. Grova, and N. , Hair analysis for the biomonitoring of pesticide exposure: comparison with blood and urine in a rat model, Arch Toxicol, vol.91, pp.2813-2825, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01573244

A. , A. Senturk, L. M. Seli, and E. , Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone, Biol Reprod, vol.61, pp.85-90, 1999.

B. , R. Gluckman, P. D. Grandjean, and P. , Developmental origins of noncommunicable disease: implications for research and public health, Environ Health, vol.11, p.42, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00712586

B. , V. Martini, E. Kallikourdis, and M. , Ovariectomy shortens the life span of female mice, Oncotarget, vol.6, pp.10801-10812, 2015.

R. N. Bergman and M. Ader, Free fatty acids and pathogenesis of type 2 diabetes mellitus, Trends Endocrinol Metab, vol.11, pp.351-357, 2000.

B. , S. B. Kahn, and C. R. , From mice to men: insights into the insulin resistance syndromes, Annu Rev Physiol, vol.68, pp.123-58, 2006.

C. , J. P. Jornayvaz, F. R. Lee, and H. Y. , Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance, Endocrinology, vol.154, pp.1021-1029, 2013.

C. , C. Desvergne, and B. , Endocrine disruptors: from endocrine to metabolic disruption, Annu Rev Physiol, vol.73, pp.135-62, 2011.

C. , H. J. Jun, H. J. Lee, and J. H. , Acute effect of high-dose isoflavones from Pueraria lobata (Willd.) Ohwi on lipid and bone metabolism in ovariectomized mice, Phytother Res, vol.26, pp.1864-71, 2012.

D. and J. L. , Metabolism, variability and risk assessment, Toxicology, vol.268, pp.156-64, 2010.

E. and E. F. , Scientific opinion on bisphenol A, 2015.

E. Additives and F. , PROCESSING AIDS AND MATERIALS IN CONTACT WITH FOOD 2005. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to bis(2ethylhexyl)phthalate (DEHP) for use in food contact materials

E. , , vol.243, pp.1-20

G. , A. C. Chappell, V. A. Fenton, and S. E. , EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals, Endocr Rev, vol.36, pp.1-150, 2015.

H. , J. J. Blumberg, B. Cave, and M. , Metabolism disrupting chemicals and metabolic disorders, Reprod Toxicol, vol.68, pp.3-33, 2017.

H. and G. S. , Inflammation and metabolic disorders, Nature, vol.444, pp.860-867, 2006.

J. , A. S. Blumberg, and B. , Obesogens: an emerging threat to public health, Am J Obstet Gynecol, vol.214, pp.559-65, 2016.

J. , K. Hoeltke, J. Nazareth, and M. , Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes, Am J Reprod Immunol, vol.51, pp.22-31, 2004.

K. , H. Tateya, S. Tamori, and Y. , MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J Clin Invest, vol.116, pp.1494-505, 2006.

K. , W. K. Choi, E. K. Sul, and O. J. , Monocyte chemoattractant protein-1 deficiency attenuates oxidative stress and protects against ovariectomy-induced chronic inflammation in mice, PLoS One, vol.8, p.72108, 2013.

L. , B. Labaronne, E. Vidal, H. Naville, and D. , Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders, World Journal of Biological Chemistry, 2017.

L. , B. Vidal, H. Naville, and D. , Lifelong consumption of low-dosed food pollutants and metabolic health, J Epidemiol Community Health, vol.69, pp.512-517, 2015.

L. , D. H. Porta, M. Jacobs, D. R. , and J. R. , Chlorinated persistent organic pollutants, obesity, and type 2 diabetes, Endocr Rev, vol.35, pp.557-601, 2014.

L. , E. H. Chapman, and H. D. , Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes, J Clin Invest, vol.93, pp.2007-2020, 1994.

M. and F. , Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity, Trends Endocrinol Metab, vol.22, pp.24-33, 2011.

M. and F. , Sex differences in metabolic homeostasis, diabetes, and obesity, Biol Sex Differ, vol.6, p.14, 2015.

M. , F. Clegg, D. J. Hevener, and A. L. , The role of estrogens in control of energy balance and glucose homeostasis, Endocr Rev, vol.34, pp.309-347, 2013.

M. , R. Teixeira, D. Calhau, and C. , Estrogen signaling in metabolic inflammation, Mediators Inflamm, p.615917, 2014.

N. , A. Quesada, I. Tuduri, and E. , Endocrine-disrupting chemicals and the regulation of energy balance, Nat Rev Endocrinol, 2017.

N. , D. Labaronne, E. Vega, and N. , Metabolic outcome of female mice exposed to a mixture of low-dose pollutants in a diet-induced obesity model, PLoS ONE, vol.10, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01848531

N. , D. Pinteur, C. Vega, and N. , Low-dose food contaminants trigger sex-specific, hepatic metabolic changes in the progeny of obese mice, FASEB J, vol.27, pp.3860-70, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00833778

N. , D. Rebourcet, D. Chauvin, and M. A. , Direct and indirect impact of 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) on adult mouse Leydig cells: an in vitro study, Toxicol Lett, vol.207, pp.251-258, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-01848522

P. , S. Singh, R. Rosenfeld, and M. E. , Estradiol suppresses MCP-1 expression In vivo : implications for atherosclerosis, Arterioscler Thromb Vasc Biol, vol.18, pp.1575-82, 1998.

R. , E. Waget, A. Cogo, and H. , Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice, Endocrinology, vol.150, pp.2109-2126, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410271

T. , A. Yasui, T. Matsui, and S. , Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition, Cytokine, vol.62, pp.86-90, 2013.

T. , S. Tamori, Y. Kawaguchi, and T. , An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice, Endocrinology, vol.151, pp.971-980, 2010.

T. , L. Zoeller, R. T. Hass, and U. , Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis, Andrology, vol.4, pp.565-72, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01500574

F. X. Van-leeuwen, M. Feeley, and D. Schrenk, Dioxins: WHO's tolerable daily intake (TDI) revisited, Chemosphere, vol.40, pp.1095-101, 2000.

L. N. Vandenberg, T. Colborn, and T. B. Hayes, Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses, Endocr Rev, vol.33, pp.378-455, 2012.

, Polychlorinated biphenyls: human health aspects. Concise International Chemical Assessement Document 55. World Health Organization, WHO 2003, 2016.

Z. , L. Brown, W. C. Cai, and Q. , Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance, Diabetes, vol.62, pp.424-458, 2013.